相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)
Madhav V. Dhodapkar et al.
BLOOD (2014)
S0120 GEMS: genomics encounters MGUS and SMM
Angela Dispenzieri
BLOOD (2014)
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma
Saad Z. Usmani et al.
BLOOD (2013)
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS
J. A. Katzmann et al.
LEUKEMIA (2013)
Expression of multiple myeloma associated markers in bone marrow spicules using a novel immunohistochemical technique
M. Santra et al.
BIOTECHNIC & HISTOCHEMISTRY (2011)
Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease
Jessica A. Fowler et al.
BLOOD (2011)
Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS
Alvin C. Ng et al.
BLOOD (2011)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
Neha Korde et al.
BLOOD (2011)
CCN1/CYR61: the very model of a modern matricellular protein
Lester F. Lau
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management
Sigurdur Y. Kristinsson et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Sclerostin binds and regulates the activity of cysteine-rich protein 61
Theodore A. Craig et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
CYR61 Regulates BMP-2-dependent Osteoblast Differentiation through the αvβ3 Integrin/Integrin-linked Kinase/ERK Pathway
Jen-Liang Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone
Angela Pennisi et al.
PLOS ONE (2010)
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
Sonia Vallet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma
Brendan M. Weiss et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
The significance of monoclonal gammopathy of undetermined significance
Robert A. Kyle et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In Vivo
Vladislava Juric et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
High-risk myeloma: a gene expression-based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone
Fenghuang Zhan et al.
BLOOD (2008)
Role of decorin in the antimyeloma effects of osteoblasts
Xin Li et al.
BLOOD (2008)
Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
Ya-Wei Qiang et al.
BLOOD (2008)
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
Ya-Wei Qiang et al.
BLOOD (2008)
Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma
Ya-Wei Qiang et al.
BONE (2008)
The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of αvβ3 and αvβ5
Julie C. Crockett et al.
ENDOCRINOLOGY (2007)
Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines
Xin Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells:: potential role in angiogenesis and endothelial regeneration
Karsten Grote et al.
BLOOD (2007)
HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma
Therese Standal et al.
BLOOD (2007)
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby et al.
BLOOD (2007)
Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation
Gregory A. Clines et al.
MOLECULAR ENDOCRINOLOGY (2007)
Multiple myeloma bone disease: pathophysiology of osteoblast inhibition
Nicola Giuliani et al.
BLOOD (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation
Aaron N. Nguyen et al.
EXPERIMENTAL CELL RESEARCH (2006)
CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells
WK Si et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma
William G. Gunn et al.
STEM CELLS (2006)
Monoclonal gammopathy of undetermined significance
Robert A. Kyle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Identification of a novel integrin αvβ3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells
NY Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
分享论文
